iPath Short Enhanced MSCI Emerging Markets Index ETN
EMSA
EMSA was delisted on the 20th of March, 2017.
0 hedge funds and large institutions have $0 invested in iPath Short Enhanced MSCI Emerging Markets Index ETN in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $449K → $0 (-$449K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$436K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$13K |
EMSA Hedge Fund Activity: Q2 2017 in Review
0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in iPath Short Enhanced MSCI Emerging Markets Index ETN (EMSA) for Q2 2017, worth a combined $0 — down 100% from $449K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of EMSA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Barclays, exiting entirely with an estimated $436K sold.
- 0 institutional investors held iPath Short Enhanced MSCI Emerging Markets Index ETN (EMSA) as of Q2 2017, down from 2 in Q1 2017.
- Funds reported $0 of iPath Short Enhanced MSCI Emerging Markets Index ETN stock for Q2 2017, down 100% quarter-over-quarter.
- 0 funds opened new iPath Short Enhanced MSCI Emerging Markets Index ETN positions in Q2 2017 and 2 closed out, a net change of -2 holders.
- The largest iPath Short Enhanced MSCI Emerging Markets Index ETN seller in Q2 2017 was Barclays, an estimated $436K sold.
Based on aggregated 13F filings for Q2 2017.